BOSTON SCIENTIFIC CORP vs EDWARDS LIFESCIENCES CORPORATION, two Medical Devices stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where BSX and EW diverge most: on debt / equity, BSX reads 0.00 and EW reads 0.06; on ev/ebitda, BSX reads 13.2 and EW reads 34.7. The rest of the comparable metrics sit closer together. What BSX's price implies is a bet that sits within the historical range (whole-company basis). What EW's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | BSX | EW |
|---|---|---|
| Price | $46.73 | $86.03 |
| Market cap | $69.9B | $50.0B |
| Sector | Medical Devices | Medical Devices |
| Stage | Growth | Growth |
| Implied growth (priced in) | +8.9% | — |
| P/E | 19.6 | 45.8 |
| P/B | 2.68 | 4.84 |
| P/S | 3.39 | 7.93 |
| EV/EBITDA | 13.2 | 34.7 |
| Revenue growth | +17.6% | +14.1% |
| Gross margin | 69.5% | 78.0% |
| Operating margin | 21.2% | 29.0% |
| Net margin | 17.3% | 17.4% |
| Return on equity | 13.6% | 10.6% |
| Return on assets | 8.0% | 8.2% |
| Return on invested capital | 11.5% | 10.2% |
| FCF yield | 5.0% | 2.2% |
| Debt / equity | 0.00 | 0.06 |
| Current ratio | 1.90 | 4.42 |
| Altman Z (solvency) | 6.88 | 8.56 |
| Piotroski F (quality) | 5 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.